← FDA Drug Approvals (Drugs@FDA)
DASATINIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2021-11-23
Drug application
- FDA Application #
ANDA203180- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DASATINIB
- Generic name
- DASATINIB
- Active ingredients
- DASATINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- APOTEX
- Manufacturer
- Apotex Corp.
- First approval
- 2021-11-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown